Alzheimer’S Clinical Neuroscience

Alzheimer's disease, a form of dementia, profoundly impacts clinical neuroscience by challenging our understanding of memory, cognition, and neural degeneration. Clinically, it manifests through progressive memory loss, cognitive decline, and behavioral changes, affecting millions worldwide. Neuroscience research delves into the pathological mechanisms involving beta-amyloid plaques and tau protein tangles, which disrupt neural communication and lead to neuronal death. Imaging techniques like MRI and PET scans aid in diagnosis by revealing brain atrophy and metabolic changes. Treatment focuses on managing symptoms and slowing progression, yet a cure remains elusive. Clinical trials explore new therapies targeting disease mechanisms, offering hope for future breakthroughs. Understanding Alzheimer's through clinical neuroscience is crucial for developing effective interventions and improving the quality of life for those affected by this devastating condition.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp